As to the laboratory tests, patients with cirrhosis had a lower level of albumin (g/L) [30.6 (6.8) vs. 32.6 (6.2), p < 0.001], alanine aminotransferase (ALT) (U/L) [173.7 (436.0) vs. 602.8 (973.0), p < 0.001], aspartate aminotransferase (AST) (U/L) [185.2 (315.0) vs. 367.0 (626.2), p < 0.001], glutamyl transferase (GGT) (U/L) [72.0 (74.2) vs. 87.2 (75.0), p = 0.004], sodium (mmol/L) [136.0 (7.0) vs. 137.0 (5.2), p < 0.001], hemoglobin [120.0 (29.0) vs. 133.0 (26.0), p < 0.001], and platelets (109/L) [83.0 (61.0) vs. 120.5 (65.0), p < 0.001] than without cirrhosis. The gene discussed is GPT; the disease is Cirrhosis.